异柠檬酸脱氢酶1(IDH1)多克隆抗体(异硫氰酸荧光素标记)

FITC-Linked Polyclonal Antibody to Isocitrate Dehydrogenase 1, Soluble (IDH1)

PICD; IDP; Oxalosuccinate decarboxylase; NADP(+)-specific ICDH; Cytosolic NADP-isocitrate dehydrogenase

  • 异柠檬酸脱氢酶1(IDH1)多克隆抗体(异硫氰酸荧光素标记) 产品包装(模拟)
  • 异柠檬酸脱氢酶1(IDH1)多克隆抗体(异硫氰酸荧光素标记) 产品包装(模拟)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对IDH1的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别IDH1。

用法

免疫印迹：0.2-2µg/mL;1:250-2500
免疫组织化学：5-20µg/mL;1:25-100
免疫细胞化学：5-20µg/mL;1:25-100
最佳稀释倍数最终由用户决定。

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号 适用物种：Mus musculus (Mouse，小鼠) 应用(仅供研究使用，不用于临床诊断！)
RPH839Mu01 异柠檬酸脱氢酶1(IDH1)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAH839Mu01 异柠檬酸脱氢酶1(IDH1)多克隆抗体 WB; IHC; ICC; IP.
LAH839Mu81 异柠檬酸脱氢酶1(IDH1)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
LAH839Mu71 异柠檬酸脱氢酶1(IDH1)多克隆抗体(生物素标记) WB; IHC; ICC.

参考文献

杂志 参考文献
Molecular & Cellular Proteomics Identification of IDH1 as a Potential Diagnostic and Prognostic Biomarker for Non-small-cell Lung Cancer by Proteomic Analysis [Mcponline: 008821]
Molecular & Cellular Proteomics Identification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis [Pubmed: 22064513]
Clinical Cancer Research Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer [Pubmed: 24046070]
Onco Targets Ther The effects of PGC-1α on the proliferation and energy metabolism of malignant endometrial cancer cells [PubMed: 25914546]
Oncogene Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism [Pubmed:29921847]
Molecular Oncology IDH 2 is a novel diagnostic and prognostic serum biomarker for non‐small‐cell lung cancer [Pubmed:29465809]
Cancers Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver … [Pubmed: 32443439]
International Journal of Cancer Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer [Pubmed:35689436]
留言咨询